Actinic Keratosis: Sinecatechins Ointment Study

We are studying a green tea extract ointment for adults with actinic keratosis on the scalp and face. The goal is to see if it clears skin lesions better than a placebo and to assess its safety.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Camellia Sinensis (Green Tea) Leaf Extract
Camellia sinensis (green tea) leaf extract is a substance rich in antioxidants used to help protect cells and support skin and general health.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Veregen

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Gemeinschaftspraxis Weber & Crainic
Gemeinschaftspraxis Weber & Crainic
Augsburg, Germany
Thermalsole und Schwefelbad Bentheim GmbH
Klinisches Studienzentrum
Bad Bentheim, Germany
St. Josef-Hospital
Klinik für Dermatologie, Venerologie und Allergologie
Bochum, Germany

Sponsor: Aresus Pharma GmbH
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.